Tirzepatide News | Live Feed & Top Stories - 쮸떴눈첵

Tirzepatide

In the last hour

InsideHook16:53

In the last 4 hours

Futurism15:03

American Journal of Managed Care14:15

In the last 8 hours

American Journal of Managed Care10:31

American Journal of Managed Care10:11

Earlier today

American Journal of Managed Care09:10

The Motley Fool04:54

Dublin Live02:01

Yesterday

News-Medical.Net23:08 17-Apr-25

EurekAlert!19:42 17-Apr-25

WA Today18:48 17-Apr-25

American Journal of Managed Care17:14 17-Apr-25

The Hollywood Gossip16:22 17-Apr-25

Benzinga15:36 17-Apr-25

American Journal of Managed Care14:21 17-Apr-25

The Washington Times13:00 17-Apr-25

American Journal of Managed Care13:00 17-Apr-25

People12:34 17-Apr-25

Pharmaceutical Technology12:33 17-Apr-25

Cleveland.com12:24 17-Apr-25

MailOnline12:16 17-Apr-25

Cleveland.com10:45 17-Apr-25

24/7 Wall St.10:24 17-Apr-25

pharmaphorum09:23 17-Apr-25

GlobeNewswire (Press Release)08:03 17-Apr-25

PR Newswire (Press Release)07:34 17-Apr-25

Yahoo! US07:01 17-Apr-25

TIME06:52 17-Apr-25

The Times of India01:32 17-Apr-25

In the last 7 days

MailOnline23:54 16-Apr-25

Cleveland.com15:28 16-Apr-25

ScienceDaily14:35 16-Apr-25

The Times of India14:30 16-Apr-25

Cleveland 1913:32 16-Apr-25

The Portugal News13:07 16-Apr-25

American Journal of Managed Care11:45 16-Apr-25

Pharmaceutical Technology11:18 16-Apr-25

American Journal of Managed Care09:42 16-Apr-25

Zacks08:06 16-Apr-25

PR Newswire (Press Release)07:08 16-Apr-25

Knowridge Science Report06:10 16-Apr-25

News-Medical.Net21:26 15-Apr-25

Benzinga15:49 15-Apr-25

Benzinga15:20 15-Apr-25

Zacks14:07 15-Apr-25

Medpage Today13:57 15-Apr-25

American Journal of Managed Care13:42 15-Apr-25

Benzinga12:22 15-Apr-25

HealthDay11:52 15-Apr-25

American Journal of Managed Care11:40 15-Apr-25

Zacks11:03 15-Apr-25

Benzinga10:23 15-Apr-25

American Journal of Managed Care09:58 15-Apr-25

MailOnline09:55 15-Apr-25

Asia Financial09:45 15-Apr-25

PR Newswire (Press Release)09:03 15-Apr-25

American Journal of Managed Care08:28 15-Apr-25

The Irish Independent08:18 15-Apr-25

GlobeNewswire (Press Release)08:02 15-Apr-25

RTT News07:49 15-Apr-25

GlobeNewswire (Press Release)07:02 15-Apr-25

Daily Record05:45 15-Apr-25

Yahoo! US05:44 15-Apr-25

Vietnam Investment Review23:02 14-Apr-25

Knowridge Science Report20:18 14-Apr-25

American Journal of Managed Care17:12 14-Apr-25

Yahoo! US15:58 14-Apr-25

The Nittany Turkey (Weblog)13:41 14-Apr-25

Pharmaceutical Technology12:20 14-Apr-25

MediaOutReach (Press Release)11:02 14-Apr-25

pharmaphorum08:19 14-Apr-25

Tyla05:54 14-Apr-25

The Mirror04:28 14-Apr-25

Science Blog (Weblog)23:43 13-Apr-25

MailOnline18:42 13-Apr-25

Fox News08:24 13-Apr-25

MailOnline22:41 12-Apr-25

Knowridge Science Report20:49 12-Apr-25

Fox News16:36 12-Apr-25

MailOnline12:01 12-Apr-25

Hindustan Times02:49 12-Apr-25

News-Medical.Net22:22 11-Apr-25

Yahoo! UK & Ireland18:06 11-Apr-25

ABC7 / KABC-TV16:35 11-Apr-25

The Independent15:38 11-Apr-25

MailOnline13:26 11-Apr-25

People11:30 11-Apr-25

Valley Independent Sentinel08:30 11-Apr-25

PR Newswire (Press Release)07:33 11-Apr-25

In the last month

Scrip Pharma Intelligence17:59 10-Apr-25

Pharmacy Times15:17 10-Apr-25

UNILAD15:12 10-Apr-25

The Tribune, California14:56 10-Apr-25

MailOnline13:42 10-Apr-25

FoodNavigator.com12:04 10-Apr-25

The House of Commons Library blog11:50 10-Apr-25

Management in Practice11:50 10-Apr-25

The Fresno Bee11:48 10-Apr-25

Science News Online11:03 10-Apr-25

MailOnline05:51 10-Apr-25

i News02:18 10-Apr-25

News-Medical.Net22:02 9-Apr-25

The Mirror18:57 9-Apr-25

Medpage Today14:27 9-Apr-25

Pharmacy Times13:02 9-Apr-25

MailOnline13:01 9-Apr-25

Business Weekly09:38 9-Apr-25

PR Newswire (Press Release)08:02 9-Apr-25

ThePrint00:09 9-Apr-25

American Journal of Managed Care16:24 8-Apr-25

The Economic Times15:29 8-Apr-25

Health Magazine12:53 8-Apr-25

The Economic Times12:46 8-Apr-25

Zacks11:18 8-Apr-25

GlobeNewswire (Press Release)08:32 8-Apr-25

view more headlines

18 Apr 16:53

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

쮸떴눈첵

Tirzepatide

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories